England’s drug approval body has resisted pressure from pharmaceutical companies to loosen its process for recommending drugs and is pressing instead for the NHS to speed up the rollout of approved ...

Top decision-makers from across the biopharma ecosystem will convene in Chicago for the 2nd BioCentury Grand Rounds – U.S., at the intersection of research, investment and drug development. Designed ...

A mineralocorticoid receptor antagonist that blocks excess aldosterone and reduces fluid volumes, spironolactone is the ...

Japanese stocks extend gains for the fourth session, mirroring Wall Street's surge. The Japanese stock market traded sharply higher extending the gains in the previous three sessions, following the ...

Drugmakers' shares fell globally after President Trump said he would [sign an executive order]( ...

Trump’s comments of "cutting out the middlemen" also weighed on shares of companies that own pharmacy benefit managers.

Shares of pharmaceutical companies declined after U.S. President Donald Trump announced plans to lower U.S. prescription drug ...

The Indian subsidiary of UK pharma major AstraZeneca has announced a Central Drugs Standard Control Organization (CDSCO) approval to import for sale and distribution of trastuzumab deruxtecan ...

TOKYO, - Japan's Nikkei share average rose on Monday as indications of progress in U.S.-China trade talks boosted hopes of a deal between the major economies. As of 0202 GMT, the Nikkei was up 0.2% at ...

Global pharmaceutical stocks dropped sharply Monday after former U.S. President Donald Trump pledged to cut prescription drug ...

Trump said his plan would see the US “pay the same price as the Nation that pays the lowest price anywhere in the World.” ...

President Trump's \"most favored nation\" policy aims to drastically lower U.S. prescription drug prices by aligning them ...